High late stage clinical failure rate, long development time, and increasing cost are unsustainable hurdles facing pharma industry. A well designed drug development process with model based approach to get a quantitative understanding of the underlying physiology of health, disease, and body's response to drugs has a huge potential (unfortunately very underutilized so far) to help pharma companies overcome this hurdle and keep a competitive edge. Octet Research Inc. provides wide range of services and solutions in the area of data analysis, mathematical & statistical modeling & simulation, and model based predictions to achieve that competitive edge.